Hexamethylmelamine, methotrexate, 5-fluorouracil as second line chemotherapy after platinum for epithelial ovarian malignancies
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 23 (3), 304-309
- https://doi.org/10.1016/0090-8258(86)90130-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatinCancer, 1984
- Whole abdominal radiation as salvage therapy for advanced stage ovarian cancerGynecologic Oncology, 1984
- Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinomaGynecologic Oncology, 1984
- Failure of hexamethylmelamine as salvage therapy in ovarian epithelial adenocarcinoma resistant to combination chemotherapyGynecologic Oncology, 1984
- Cis‐diamminedichloroplatinum (II): Second line induction chemotherapy in advanced ovarian adenocarcinomaJournal of Surgical Oncology, 1983
- High-dose medroxyprogesterone acetate (MPA) in advanced epithelial ovarian cancer resistant to first- or second-line chemotherapyGynecologic Oncology, 1981
- Advanced ovarian carcinoma: A prospective and randomized clinical trial of cyclophosphamide versus combination cytotoxic chemotherapy (Hexa-CAF)Cancer, 1981
- High-dose platinum for the treatment of refractory ovarian cancerGynecologic Oncology, 1981
- Advanced Ovarian AdenocarcinomaNew England Journal of Medicine, 1978
- PROGESTOGEN THERAPY FOR OVARIAN CARCINOMABJOG: An International Journal of Obstetrics and Gynaecology, 1972